Community Case Management of Chest Indrawing Pneumonia

• Status: Completed
• Trial end date: 2018-08-31
• Target enrollment: 0
• Participant gender: All

Summary

This one-arm safety intervention study is aimed at increasing access to treatment of pneumonia by training CHWs, locally referred to as Community Oriented Resource Persons (CORPs), to manage chest indrawing pneumonia using oral amoxicillin, conducting follow-ups and recording their findings in case report forms. CORPs will also be involved in improving care seeking for pneumonia in children by training them to conduct health education sessions for men and women in their respective communities.

The primary objective is to assess if CORPs can safely and appropriately manage chest indrawing pneumonia in 2-59 month old children, and refer children with danger signs. The primary outcomes will be the proportion of children under five with chest indrawing pneumonia who were managed appropriately by CORPs and the clinical treatment failure of chest indrawing pneumonia. Secondary outcomes will include proportion of children with chest indrawing followed up by CORPs on day 3 and caregiver adherence to treatment for CI, and clinical relapse of pneumonia between day 7 to 14 among children whose signs of pneumonia disappeared by day 6. Approximately 308 children 2-59 months of age with chest indrawing pneumonia would be needed for this safety intervention study.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Malaria Consortium
• Collaborator: World Health Organization
• Treatments: Amoxicillin

Criteria

Inclusion Criteria:

• Chest indrawing pneumonia

Exclusion Criteria:

• Convulsions

• Cough for 14 days or more

• Blood in stool

• Fever for last 7 days or more

• Diarrhoea for 14 days or more

• Not able to drink or feed anything

• Unusually sleepy or unconscious

• Vomits everything

• Swelling of both feet

• Red on MUAC strap (severe acute malnutrition)